Pierre L Triozzi Selected Research

CTP37 peptide

7/2002

Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre L Triozzi Research Topics

Disease

31	Neoplasms (Cancer) 10/2022 - 06/2003
19	Uveal melanoma 01/2020 - 05/2008
16	Melanoma (Melanoma, Malignant) 10/2022 - 01/2005
7	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2004 - 07/2002
2	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 01/2018
2	Disease Progression 01/2019 - 02/2012
2	Experimental Melanoma 09/2012 - 02/2010
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 10/2022
1	Testicular Neoplasms (Testicular Cancer) 01/2022
1	Monosomy 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Breast Neoplasms (Breast Cancer) 10/2017
1	Circulating Neoplastic Cells 05/2014
1	Necrosis 09/2012
1	Urticaria (Hives) 12/2006
1	Prostatic Neoplasms (Prostate Cancer) 12/2005
1	Mesothelioma 01/2005
1	Fowlpox 01/2005

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2011
8	AntigensIBA 01/2022 - 06/2003
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2012 - 06/2003
4	CytokinesIBA 10/2017 - 01/2005
4	VaccinesIBA 09/2012 - 01/2004
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2011
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2005
3	MicroRNAs (MicroRNA)IBA 12/2016 - 04/2014
3	AntibodiesIBA 12/2006 - 07/2002
2	RNA (Ribonucleic Acid)IBA 10/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2022
2	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 12/2012
2	LigandsIBA 01/2019 - 01/2019
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2015 - 09/2012
2	Differentiation AntigensIBA 12/2015 - 07/2005
2	Epithelial Cell Adhesion MoleculeIBA 05/2014 - 01/2004
2	Interleukin-2 (IL2)IBA 09/2012 - 05/2011
2	Interleukin-1 (Interleukin 1)IBA 07/2011 - 02/2010
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 07/2011 - 02/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2011 - 06/2005
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 07/2011 - 02/2010
2	Imiquimod (Aldara)FDA LinkGeneric 05/2011 - 11/2010
2	Docetaxel (Taxotere)FDA Link 02/2010 - 12/2005
2	Temozolomide (Temodar)FDA LinkGeneric 02/2010 - 12/2008
2	Immunoglobulin G (IgG)IBA 12/2006 - 01/2005
2	DNA VaccinesIBA 07/2005 - 01/2005
2	Interleukin-12 (IL 12)IBA 06/2005 - 01/2005
2	Carcinoembryonic AntigenIBA 01/2005 - 09/2004
2	Peptides (Polypeptides)IBA 06/2003 - 07/2002
1	Immune Checkpoint ProteinsIBA 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	pembrolizumabIBA 01/2019
1	Type 1 Melanocortin ReceptorIBA 01/2019
1	ChemokinesIBA 01/2019
1	CC ChemokinesIBA 01/2019
1	Endoplasmic Reticulum Chaperone BiPIBA 10/2017
1	IpilimumabIBA 10/2017
1	Conditioned Culture MediaIBA 10/2017
1	Phosphopyruvate Hydratase (Enolase)IBA 12/2015
1	ParaffinIBA 07/2014
1	Formaldehyde (Formol)FDA Link 07/2014
1	MART-1 AntigenIBA 05/2014
1	Angiogenesis InhibitorsIBA 07/2013
1	Insulin-Like Growth Factor Binding Protein 3IBA 02/2013
1	Insulin-Like PeptidesIBA 02/2013
1	Carrier Proteins (Binding Protein)IBA 02/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 02/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2013
1	Vascular Endothelial Growth FactorsIBA 09/2012
1	Toll-Like Receptor 9IBA 09/2012
1	Decitabine FDA Link 09/2012
1	Immunologic Factors (Immunomodulators)IBA 02/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 07/2011
1	Periodic AcidIBA 07/2011
1	Interleukin-6 (Interleukin 6)IBA 07/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2008
1	Imatinib Mesylate (Gleevec)FDA Link 12/2008
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 12/2008
1	ecromeximabIBA 12/2006
1	GangliosidesIBA 12/2006
1	Monoclonal AntibodiesIBA 12/2006
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2005
1	AndrogensIBA 12/2005
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2005
1	Diphtheria-Tetanus VaccineIBA 12/2005
1	Hormones (Hormone)IBA 12/2005
1	GonadotropinsIBA 12/2005
1	DNA (Deoxyribonucleic Acid)IBA 07/2005
1	Interleukin-10 (Interleukin 10)IBA 06/2005
1	AsbestosIBA 01/2005
1	Biological ProductsIBA 01/2005
1	Interferon-gamma (Interferon, gamma)IBA 01/2005

Therapy/Procedure

12	Therapeutics 01/2022 - 05/2008
8	Immunotherapy 01/2022 - 07/2002
4	Drug Therapy (Chemotherapy) 01/2019 - 12/2005
2	Aftercare (After-Treatment) 10/2014 - 07/2013
1	Brachytherapy 02/2013
1	Premedication 12/2006